Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug-induced arrhythmia: pharmacogenomic prescribing?

European heart journal - 1 Jan 2013

Behr Elijah R, Roden Dan

Abstract excerpt

Drug-induced Torsades de Pointes is a rare, unpredictable, and life-threatening serious adverse event. It can be caused by both cardiac and non-cardiac drugs and has become a major issue in novel drug development and for the regulatory authorities. This review describes the problem, predisposing factors, and the underlying genetic predisposition as it is understood currently. The future potential for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ion Channels
Share to Long QT Syndrome
Share to Anti-Arrhythmia Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electrocardiography

Share to Genome-Wide Association Study

Share to Polymorphism, Genetic

Share to Risk Factors

Share to Torsades de Pointes

Source

Open in PubMed Open full text

Identifiers

PMID: 23091201
DOI: 10.1093/eurheartj/ehs351
PMCID: PMC3538275

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug-induced arrhythmia: pharmacogenomic prescribing?PMID 23091201Read ↗

The genetics of pro-arrhythmic adverse drug reactions.Semantic proximity Read ↗

Drug-induced torsades de pointes: the evolving role of pharmacogenetics.Semantic proximity Read ↗

Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.Semantic proximity Read ↗

Pharmacogenetics and drug-induced arrhythmiasSemantic proximity Read ↗

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update.Semantic proximity Read ↗

Drug-induced Brugada syndrome by noncardiac agents.Semantic proximity Read ↗

Genetic and Molecular Aspects of Drug-Induced QT Interval ProlongationSemantic proximity Read ↗

Drug‐ and non‐drug‐associated QT interval prolongationSemantic proximity Read ↗

Molecular predictors of drug-induced prolongation of the QT interval.Semantic proximity Read ↗

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized MedicineSemantic proximity Read ↗

Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.Semantic proximity Read ↗

Pharmacogenomics and Acquired Long QT SyndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.